BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 305546)

  • 41. [Immunologic reactivity in uremic patients in hemodialysis].
    Rotolo U
    Recenti Prog Med; 1979 Feb; 66(2):116-23. PubMed ID: 312517
    [No Abstract]   [Full Text] [Related]  

  • 42. Plasma catecholamines, neuropeptide Y and leucine-enkephalin in uremic patients before and after dialysis during rest and handgrip.
    Klin M; Waluga M; Rudka R; Madej A; Janiszewska M; Grzebieniak E; Wesolowky A
    Boll Chim Farm; 1998 Sep; 137(8):306-13. PubMed ID: 9835145
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunologic disturbances and levels of parathyroid hormone in uremic patients in replacement dialysis therapy.
    Angelini D; Carlini A; Mazzotta L; Mei E; Grassi R; Giusti R; Neri M; Fiorini I; Antonelli A
    Clin Nephrol; 1994 Oct; 42(4):246-50. PubMed ID: 7834917
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Naïve and central memory T-cell lymphopenia in end-stage renal disease.
    Yoon JW; Gollapudi S; Pahl MV; Vaziri ND
    Kidney Int; 2006 Jul; 70(2):371-6. PubMed ID: 16738532
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of uraemic "middle-sized molecules" on T lymphocyte functions.
    Kálmán K; Löcsey L; Hauck M; Leövey A
    Int Urol Nephrol; 1980; 12(4):367-74. PubMed ID: 6763010
    [TBL] [Abstract][Full Text] [Related]  

  • 46. T mediated immunity in patients undergoing periodic hemodialysis.
    Piazza I; Alibrandi F; Semenzato G; Battistella L; Amadori G; Gasparotto G
    Boll Ist Sieroter Milan; 1978 Nov; 57(5):631-6. PubMed ID: 314813
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The lymphocyte response to influenza in humans.
    Criswell BS; Couch RB; Greenberg SB; Kimzey SL
    Am Rev Respir Dis; 1979 Sep; 120(3):700-4. PubMed ID: 314763
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immune alterations in hemodialyzed patients. I. Effect of blood transfusion on T-lymphocyte subpopulations in hemodialyzed patients.
    Nanishi F; Inenaga T; Onoyama K; Oh Y; Oochi N; Fujishima M
    J Clin Lab Immunol; 1986 Apr; 19(4):167-74. PubMed ID: 2941588
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thoracoscopic talc poudrage decreases T-lymphocytes in the peripheral blood.
    Froudarakis ME; Papadaki HA; Klimathianaki M; Damianaki A; Pougounias M; Kotsianidis I; Astoul P
    Respir Med; 2007 Jun; 101(6):1212-7. PubMed ID: 17182238
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinico-immunologic correlations and various characteristics of the lymphocyte receptors in hepatocerebral dystrophy].
    Gannushkina IV; Zhirnova IG; Chlonkovska A; Markova ED; Ivanova-Smolenskaia IA; Poleshchuk VV; Komel'kova LV; Katosova RK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(3):49-52. PubMed ID: 2163169
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of uremic middle molecules on in vitro stimulated lymphocytes and interleukin-2 production.
    Severini G; Diana L; Di Giovannandrea R; Sagliaschi G
    ASAIO J; 1996; 42(1):64-7. PubMed ID: 8808461
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparison of hemodialysis and transplantation in reversing the uremic disturbance of male reproductive function.
    Holdsworth SR; de Kretser DM; Atkins RC
    Clin Nephrol; 1978 Oct; 10(4):146-50. PubMed ID: 363318
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deoxyribonuclease activity in T and B lymphocytes of haemodialysed patients with uraemia.
    Adamiec R; Szewczyk Z; Szopa J
    Int Urol Nephrol; 1992; 24(1):95-101. PubMed ID: 1624250
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Erythropoiesis activity, iron availability and reticulocyte hemoglobinization during treatment with hemodialysis and in subjects with uremia.
    Schoorl M; Schoorl M; Nubé MJ; Bartels PC
    Clin Lab; 2006; 52(11-12):621-9. PubMed ID: 17175894
    [TBL] [Abstract][Full Text] [Related]  

  • 55. T4 lymphopenia in patients with active pulmonary tuberculosis.
    Beck JS; Potts RC; Kardjito T; Grange JM
    Clin Exp Immunol; 1985 Apr; 60(1):49-54. PubMed ID: 3874015
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cellular immunity and levels of parathyroid hormone in uremic patients receiving hemodialysis.
    Griveas I; Visvardis G; Papadopoulou D; Mitsopoulos E; Kyriklidou P; Manou E; Meimaridou D; Ginikopoulou E; Sakellariou G; Fleva A; Zilidou R; Paulitou A
    Ren Fail; 2005; 27(3):275-8. PubMed ID: 15957542
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diamine oxidase activity in plasma and urine in uremia.
    Tam CF; Kopple JD; Wang M; Swendseid ME
    Nephron; 1979; 23(1):23-7. PubMed ID: 109782
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The ability of uremic serum to induce neutrophil chemotaxis in relation to hemodialysis.
    Pedersen JO; Knudsen F; Nielsen AH; Grunnet N
    Blood Purif; 1987; 5(1):24-8. PubMed ID: 3790268
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Eosinophilia in uremia.
    Gabizon D; Kaufman S; Shaked U; Evans SY; Modai D
    Nephron; 1981; 29(1-2):36-9. PubMed ID: 7329471
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum endorphin levels in uremic patients under maintenance hemodialysis.
    Hwang JC; Hsu KT; Tsai HC; Lam KK; Wang PW
    Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):360-5. PubMed ID: 2529347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.